GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
C86.6
Primary cutaneous CD30-positive T-cell proliferations
ICD10CM code
Medical Policies and Guidelines for Primary cutaneous CD30-positive T-cell proliferations
Related policies from health plans
ANTHEM-BLUECROSS-CA
Adcetris (brentuximab)
ANTHEM-BLUECROSS-CA
Istodax (romidepsin)
ANTHEM-BLUECROSS-CA
Ultraviolet Light Therapy Delivery Devices for Home Use
ANTHEM-BLUECROSS-CT
CG-DME-41 Ultraviolet Light Therapy Delivery Devices for Home Use
ANTHEM-BLUECROSS-CT
SURG.00023 Breast Procedures; including Reconstructive Surgery, Implants and Other Breast Procedures
Similar Codes
ICD10CM codes
C86.6
- Primary cutaneous CD30-positive T-cell proliferations
C84.A
- Cutaneous T-cell lymphoma, unspecified
C86.3
- Subcutaneous panniculitis-like T-cell lymphoma
C84.A9
- Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites
C84.A0
- Cutaneous T-cell lymphoma, unspecified, unspecified site
C84.A8
- Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites
C88.7
- Other malignant immunoproliferative diseases
C84.A7
- Cutaneous T-cell lymphoma, unspecified, spleen
C88.8
- Other malignant immunoproliferative diseases
C84.A1
- Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck
HCPCS codes
G9785
- Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to
G8721
- Pt category (primary tumor), pn category (regional lymph nodes), and histologic grade were documente
D7430
- Excision of benign tumor-lesion diameter up to 1.25 cm
G8875
- Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
Q4136
- Ez-derm, per square centimeter
Q2043
- Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leuk
Q2041
- Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, includi
Q4106
- Dermagraft, per square centimeter
G9842
- Patient has metastatic disease at diagnosis
D7411
- EXCISION OF BENIGN LESION GREATER THAN 1.25 CM
CPT4 codes
17107
- Destruction of cutaneous vascular proliferative lesions (eg, laser technique); 10.0 to 50.0 sq cm
17106
- Destruction of cutaneous vascular proliferative lesions (eg, laser technique); less than 10 sq cm
17108
- Destruction of cutaneous vascular proliferative lesions (eg, laser technique); over 50.0 sq cm
11102
- Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion
88230
- Tissue culture for non-neoplastic disorders; lymphocyte
88239
- Tissue culture for neoplastic disorders; solid tumor
11103
- Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); each separate/additional lesion (L
88233
- Tissue culture for non-neoplastic disorders; skin or other solid tissue biopsy
0089U
- Oncology (melanoma), gene expression profiling by RTqPCR, PRAME and LINC00518, superficial collectio
11100
- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherw